In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of CRISPR Therapeutics AG (NASDAQ: CRSP) closed at $53.29 in the last session, down -4.03% from day before closing price of $55.53. In other words, the price has decreased by -$4.03 from its previous closing price. On the day, 1.52 million shares were traded. CRSP stock price reached its highest trading level at $54.5 during the session, while it also had its lowest trading level at $52.62.
Ratios:
We take a closer look at CRSP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.54 and its Current Ratio is at 17.54. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 11, 2023, TD Cowen Downgraded its rating to Underperform which previously was Market Perform but kept the price unchanged to $30.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 15 ’24 when Kulkarni Samarth sold 19,582 shares for $59.91 per share. The transaction valued at 1,173,232 led to the insider holds 208,122 shares of the business.
Kulkarni Samarth sold 20,000 shares of CRSP for $1,449,628 on Mar 15 ’24. The Chief Executive Officer now owns 208,122 shares after completing the transaction at $72.48 per share. On Mar 15 ’24, another insider, Prasad Raju, who serves as the Chief Financial Officer of the company, sold 3,524 shares for $72.69 each. As a result, the insider received 256,160 and left with 6,476 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRSP now has a Market Capitalization of 4523420672 and an Enterprise Value of 3002663424. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.19 while its Price-to-Book (P/B) ratio in mrq is 2.27. Its current Enterprise Value per Revenue stands at 8.089 whereas that against EBITDA is -14.813.
Stock Price History:
Over the past 52 weeks, CRSP has reached a high of $91.10, while it has fallen to a 52-week low of $37.55. The 50-Day Moving Average of the stock is -20.36%, while the 200-Day Moving Average is calculated to be -10.37%.
Shares Statistics:
According to the various share statistics, CRSP traded on average about 1.72M shares per day over the past 3-months and 1271950 shares per day over the past 10 days. A total of 84.88M shares are outstanding, with a floating share count of 81.24M. Insiders hold about 4.30% of the company’s shares, while institutions hold 65.69% stake in the company. Shares short for CRSP as of 1713139200 were 14744982 with a Short Ratio of 8.59, compared to 1710460800 on 14724239. Therefore, it implies a Short% of Shares Outstanding of 14744982 and a Short% of Float of 19.700001.
